Literature DB >> 8636820

Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia.

B Brichard1, C Vermylen, J Ninane, G Cornu.   

Abstract

A girl with sickle cell anemia was treated with cord blood transplantation combined with hematopoietic growth factor. Cord blood cells were collected from a sister with an identical human leukocyte antigen complex who was a carrier of the sickle cell trait (hemoglobin AS). The patient had complete engraftment and no graft-versus-host disease. The persistence of a high level of fetal hemoglobin 6 months after engraftment was noted.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8636820     DOI： 10.1016/s0022-3476(96)70398-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  5 in total

1.  Cord blood banking.

Authors: 
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

2.  The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Authors:  Courtney D Fitzhugh; Mark C Walters
Journal:  Blood Adv       Date:  2017-12-08

Review 3.  Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.

Authors:  Courtney D Fitzhugh; Allistair A Abraham; John F Tisdale; Matthew M Hsieh
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-29       Impact factor: 3.722

Review 4.  Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; John F Tisdale
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

5.  Hematopoietic stem cell transplantation for people with sickle cell disease.

Authors:  Chioma Oringanje; Eneida Nemecek; Oluseyi Oniyangi
Journal:  Cochrane Database Syst Rev       Date:  2020-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.